Results 11 to 20 of about 3,822 (260)

Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness

Zhongguo shuxue zazhi, 2022
Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to patients who require repeatedly ...
Juan SAI, Li TIAN
doaj   +2 more sources

Identification of platelet refractoriness in oncohematologic patients [PDF]

Clinics, 2011
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic patients. INTRODUCTION: Platelet refractoriness (unsatisfactory post-transfusion platelet increment) is a severe problem that impairs the treatment of ...
Aline Aparecida Ferreira, Roberto Zulli, Sheila Soares, Vagner de Castro, Helio Moraes-Souza   +4 more
doaj   +6 more sources

Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis. [PDF]

Front Med (Lausanne), 2022
Liu Y, Zhang Y, Chen D, Fu Y.
europepmc   +2 more sources

[Incidence and clinical significance of platelet transfusion refractoriness after allogeneic hematopoietic stem cell transplantation in patients with chronic myelomonocytic leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2022
Zhao C, Zhao XS, Wang Y, Yan CH, Xu LP, Zhang XH, Liu KY, Huang XJ, Sun YQ.   +8 more
europepmc   +3 more sources

Changes in inflammatory responses and autophagy during apheresis platelet preservation and their correlation with platelet transfusion refractoriness in patients with acute lymphoblastic leukemia. [PDF]

Biomol Biomed, 2023
Li Y, Song Z, Sun X, Tang J, Zhou X.
europepmc   +3 more sources

Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders. [PDF]

Oman Med J, 2022
Neanaey WA, Deghady AA, Nafea DA, Fahmy NM, Gouda AM.   +4 more
europepmc   +2 more sources

The use of splenectomy to manage platelet transfusion refractoriness due to anti-human leukocyte antibodies in allogeneic stem cell transplantation [PDF]

Pediatric Reports, 2016
In patients undergoing hematopoietic stem cell transplantation (HSCT), refractoriness to platelet transfusion has been associated with graft failure, delayed engraftment, early mortality and decreased overall survival.
Margherita Mauro, Francesco Camoglio, Pierluigi Piccoli, Massimiliano De Bortoli, Rita Balter, Anna Pegoraro, Simone Cesaro   +6 more
doaj   +2 more sources

A case of platelet transfusion refractoriness in a CD36-negative patient with acute myeloid leukemia: Diagnostic and therapeutic management. [PDF]

Transfusion, 2022
Pedini P, Hicheri Y, Bertand G, Dettori I, Basire A, Lazaygues C, Chabrières C, Perrin C, Pascal J, Chiaroni J, Renac V, Ladaique P, Vey N, Picard C.   +13 more
europepmc   +3 more sources

Platelet transfusion refractoriness within one month post-hematopoietic stem cell transplantation does not impair survival in aplastic anemia patients after engraftment: a propensity score-matched analysis. [PDF]

Front Immunol
Wang Y, Zhang Y, Liu L, Zhang T, Sun J, Chen X, Yang D, Pang A, Zhang R, Ma Q, Zhai W, He Y, Wei J, Cao Y, Liang C, Jiang E, Han M, Feng S.   +17 more
europepmc   +3 more sources

Platelet transfusion refractoriness: how do I diagnose and manage? [PDF]

Hematology Am Soc Hematol Educ Program, 2020
Cohn CS.
europepmc   +3 more sources